mimmunМедицинская иммунологияMedical Immunology (Russia)1563-06252313-741XSPb RAACI10.15789/1563-0625-2009-1-85-90mimmun-221Research ArticleКРАТКИЕ СООБЩЕНИЯSHORT COMMUNICATIONSДИСФУНКЦИЯ СИСТЕМЫ КОМПЛЕМЕНТА ПРИ СЕМЕЙНОЙ СРЕДИЗЕМНОМОРСКОЙ ЛИХОРАДКЕDYSFUNCTION OF COMPLEMENT SYSTEM IN FAMILIAL MEDITERRANEAN FEVERМкртчянГ. М.MkrtchyanG. M.aboyaiyan@sci.amОганесянЛ. П.HovhannisyanL. P.aboyaiyan@sci.amАйвазянА. А.AyvazyanA. A.
кафедра внутренних болезней № 1
aboyaiyan@sci.amНазаретянЭ. Е.NazaretyanE. Y.
кафедра внутренних болезней № 1
aboyaiyan@sci.amБояджянА. С.BoyajyanA. S.aboyaiyan@sci.amИнститут молекулярной биологии Национальной академии наук Республики Армения, г. ЕреванАрменияЕреванский государственный медицинский университетАрмения2009170720141118590Copyright © Мкртчян Г.М., Оганесян Л.П., Айвазян А.А., Назаретян Э.Е., Бояджян А.С., 20142014Мкртчян Г.М., Оганесян Л.П., Айвазян А.А., Назаретян Э.Е., Бояджян А.С.Mkrtchyan G.M., Hovhannisyan L.P., Ayvazyan A.A., Nazaretyan E.Y., Boyajyan A.S.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.mimmun.ru/mimmun/article/view/221альтернативный путь комплементаклассический путь комплементасемейная средиземноморская лихорадкаalternative complement pathwayclassic complement pathwayfamilial mediterranean feverReferencesAkcan Y., Bayraktar Y., Arslan S., VanThiel D.H., Zerrin B.C., Yildiz O. The importance of serial measurements of cytokine levels for the evaluation of their role in pathogenesis in familial Mediterraean fever//Eur J Med Res. -2003. -Vol. 8. -P. 304-306.Akcan Y., Bayraktar Y., Arslan S., VanThiel D.H., Zerrin B.C., Yildiz O. The importance of serial measurements of cytokine levels for the evaluation of their role in pathogenesis in familial Mediterraean fever//Eur J Med Res. -2003. -Vol. 8. -P. 304-306.Ayesh S.K., Azar Y., Babior B.M., Matzner Y. Inactivation of Interleukin-8 by the CSa-Inactivating Protease From Serosal Fluid//Blood. -1993. -Vol. 81, N 6. -P. 1424-1427.Ayesh S.K., Azar Y., Babior B.M., Matzner Y. Inactivation of Interleukin-8 by the CSa-Inactivating Protease From Serosal Fluid//Blood. -1993. -Vol. 81, N 6. -P. 1424-1427.Ben-Chetrit E., Backenroth R., Haimov-Kochman R., Pizov G. Azoospermia in familial Mediterranean fever patients: the role of colchicine and amyloidosis//Ann Rheum Dis. -1998. -Vol. 57, N 4. -P. 259-260.Ben-Chetrit E., Backenroth R., Haimov-Kochman R., Pizov G. Azoospermia in familial Mediterranean fever patients: the role of colchicine and amyloidosis//Ann Rheum Dis. -1998. -Vol. 57, N 4. -P. 259-260.Ben-Chetrit E., Familial Mediterranean fever (FMF) and renal AA amyloidosis. Phenotype-genotype correlation, treatment and prognosis//J. Nefrol. -2003. -Vol. 16. -P. 431-434.Ben-Chetrit E., Familial Mediterranean fever (FMF) and renal AA amyloidosis. Phenotype-genotype correlation, treatment and prognosis//J. Nefrol. -2003. -Vol. 16. -P. 431-434.Ben-Chetrit E., Levy M. Colchicine update -1998//Semin Arthritis Rheum. -1998. -Vol. 28. -P. 48-59.Ben-Chetrit E., Levy M. Colchicine update -1998//Semin Arthritis Rheum. -1998. -Vol. 28. -P. 48-59.Ben-Chetrit E., Levy M. Familial Mediterranean fever//Lancet. -1998. -Vol. 351. -P. 659-664.Ben-Chetrit E., Levy M. Familial Mediterranean fever//Lancet. -1998. -Vol. 351. -P. 659-664.Bíró A., Rovó Z., Papp D., Cervenak L., Varga L., F st G., Thielens N.M., Arlaud G.J., Prohászka Z. Studies on the interactions between C-reactive protein and complement proteins//Immunology. -2007. -Vol. 121, N 1. -P. 40-50.Bíró A., Rovó Z., Papp D., Cervenak L., Varga L., F st G., Thielens N.M., Arlaud G.J., Prohászka Z. Studies on the interactions between C-reactive protein and complement proteins//Immunology. -2007. -Vol. 121, N 1. -P. 40-50.Cerquaglia C., Diaco M., Nucera G., La Regina M., Montalto M., Manna R. Pharmacological and clinical basis of treatment of Familial Mediterranean fever (FMF) with colchicine or analogues: an update//Curr. Drug. Targets Inflamm. Allergy. -2005. -Vol. 4, N 1. -P. 117-124.Cerquaglia C., Diaco M., Nucera G., La Regina M., Montalto M., Manna R. Pharmacological and clinical basis of treatment of Familial Mediterranean fever (FMF) with colchicine or analogues: an update//Curr. Drug. Targets Inflamm. Allergy. -2005. -Vol. 4, N 1. -P. 117-124.French FMF Consortium. A candidate gene for familial Mediterranean fever//Nat. Genet. -1997. -Vol. 17. -P. 25-31.French FMF Consortium. A candidate gene for familial Mediterranean fever//Nat. Genet. -1997. -Vol. 17. -P. 25-31.Gang N., Drenth J.P., Langevitz P. Activation of the cytokine network in familial Mediterranean fever//J. Rheumatol. -1999. -Vol. 26. -P. 890-897.Gang N., Drenth J.P., Langevitz P. Activation of the cytokine network in familial Mediterranean fever//J. Rheumatol. -1999. -Vol. 26. -P. 890-897.Goldfinger S.E. Colchicine for familial Mediterranean fever//N. Engl. J. Med. -1972. -Vol. 287. -P. 1302.Goldfinger S.E. Colchicine for familial Mediterranean fever//N. Engl. J. Med. -1972. -Vol. 287. -P. 1302.Holers V.M. The complement system as a therapeutic target in autoimmunity//Clin. Immunol. -2003. -Vol. 107, N 3. -P. 140-151.Holers V.M. The complement system as a therapeutic target in autoimmunity//Clin. Immunol. -2003. -Vol. 107, N 3. -P. 140-151.International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever//Cell. -1997. -Vol. 90. -P. 797-807.International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever//Cell. -1997. -Vol. 90. -P. 797-807.Korkmaz C., Ozdogan H., Kasapcopur O.,Yazici H. Acute phase response in familial Mediterranean fever//Ann. Rheum. Dis. -2002. -Vol. 61, N 1. -P. 79-81.Korkmaz C., Ozdogan H., Kasapcopur O.,Yazici H. Acute phase response in familial Mediterranean fever//Ann. Rheum. Dis. -2002. -Vol. 61, N 1. -P. 79-81.Le G.T., Abbenante G., Fairlie D.P. Profiling the enzymatic properties and inhibition of human complement factor B//J. Biol. Chem. 2007. -Vol. 282, N 48. -P. 34809-34816.Le G.T., Abbenante G., Fairlie D.P. Profiling the enzymatic properties and inhibition of human complement factor B//J. Biol. Chem. 2007. -Vol. 282, N 48. -P. 34809-34816.Lidar M., Scherrman J.M., Shinar Y., Chetrit A., Niel E., Gershoni-Baruch R., Langevitz P., Livneh A. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization//Semin. Arthritis Rheum. -2004. -Vol. 33, N 4. -P. 273-282.Lidar M., Scherrman J.M., Shinar Y., Chetrit A., Niel E., Gershoni-Baruch R., Langevitz P., Livneh A. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization//Semin. Arthritis Rheum. -2004. -Vol. 33, N 4. -P. 273-282.Linneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T. Criteria for the diagnosis of familial Mediterranean fever//Arthritis Rheum. -1997. -Vol. 40. -P. 1879-1885.Linneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T. Criteria for the diagnosis of familial Mediterranean fever//Arthritis Rheum. -1997. -Vol. 40. -P. 1879-1885.Matzner Y., Abedat S., Shapiro E., Eisenberg S., Bar-Gil-Shitrit A., Stepensky P., Calco S., Azar Y.,Urieli-Shoval S. Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures//Blood. -2000. -Vol. 96, N 2. -P. 727-731.Matzner Y., Abedat S., Shapiro E., Eisenberg S., Bar-Gil-Shitrit A., Stepensky P., Calco S., Azar Y.,Urieli-Shoval S. Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures//Blood. -2000. -Vol. 96, N 2. -P. 727-731.Medlej-Hashim M., Loiselet J., Lefranc G.,Megarbane A. Familial Mediterranean fever (FMF): from diagnosis to treatment//Sante. -2004. -Vol. 14, N 4. -P. 261-266.Medlej-Hashim M., Loiselet J., Lefranc G.,Megarbane A. Familial Mediterranean fever (FMF): from diagnosis to treatment//Sante. -2004. -Vol. 14, N 4. -P. 261-266.Melamed A., Cabili S., Zakuth V., Spirer Z. The immune regulation in familial Mediterranean fever//J. Clin. Lab. Immunol. -1988. -Vol. 26. -P. 125-128.Melamed A., Cabili S., Zakuth V., Spirer Z. The immune regulation in familial Mediterranean fever//J. Clin. Lab. Immunol. -1988. -Vol. 26. -P. 125-128.Mйry J.P., Kenouch S. Familial Mediterranean fever associated amyloidosis//Renal Failure. -1993. -Vol. 15. -P. 379-384.Mйry J.P., Kenouch S. Familial Mediterranean fever associated amyloidosis//Renal Failure. -1993. -Vol. 15. -P. 379-384.Mkrtchyan G.M., Boyajyan A.S.,Ayvazyan A.A., Beglaryan A.A. Classical pathway complement activity in Familial Mediterranean fever//Clin. Biochem. -2006. -Vol. 39, N 7. -P. 688-691.Mkrtchyan G.M., Boyajyan A.S.,Ayvazyan A.A., Beglaryan A.A. Classical pathway complement activity in Familial Mediterranean fever//Clin. Biochem. -2006. -Vol. 39, N 7. -P. 688-691.Mkrtchyan G.M., Boyajyan A.S.,Karageuzyan K.G., Ayvazyan A.A., Pashinyan S.H., Nazaretyan E.Ye. Protein composition of circulating immune complexes in patients with Periodic disease complicated or not complicated by renal amyloidosis//Dokl. Biol. Sci. -2002. -Vol. 385. -P. 329-330.Mkrtchyan G.M., Boyajyan A.S.,Karageuzyan K.G., Ayvazyan A.A., Pashinyan S.H., Nazaretyan E.Ye. Protein composition of circulating immune complexes in patients with Periodic disease complicated or not complicated by renal amyloidosis//Dokl. Biol. Sci. -2002. -Vol. 385. -P. 329-330.Mollnes T.E., Song W.-C., Lambris J.D. Complement in inflammatory tissue damage and disease//Trends Immunol. Today. -2002. -Vol. 23, N2. -P. 61-66.Mollnes T.E., Song W.-C., Lambris J.D. Complement in inflammatory tissue damage and disease//Trends Immunol. Today. -2002. -Vol. 23, N2. -P. 61-66.Morgan B.P. Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates//Methods in Molecular Biology. Complement Methods and Protocols/Ed. Morgan B.P. -Humana Press, 2000. -P. 61-71.Morgan B.P. Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates//Methods in Molecular Biology. Complement Methods and Protocols/Ed. Morgan B.P. -Humana Press, 2000. -P. 61-71.Odabas A.R., Cetinkaya R., Selcuk Y., Keles S., Bilen H. Serum C-reactive protein levels during attack-free periods of familial Mediterranean fever//The Pain Clinic -2002. -Vol. 13, N 4. -P. 319-321.Odabas A.R., Cetinkaya R., Selcuk Y., Keles S., Bilen H. Serum C-reactive protein levels during attack-free periods of familial Mediterranean fever//The Pain Clinic -2002. -Vol. 13, N 4. -P. 319-321.Schattner A., Lachmi M., Livneh A., Pras M., Hahn T. Tumor necrosis factor in familial Mediterranean fever//Am. J. Med. -1991. -Vol. 90. -P. 434-438.Schattner A., Lachmi M., Livneh A., Pras M., Hahn T. Tumor necrosis factor in familial Mediterranean fever//Am. J. Med. -1991. -Vol. 90. -P. 434-438.Sj berg A.P., Trouw L.A., McGrath F.D.,Hack C.E., Blom A.M. Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein//J. Immunol. -2006. -Vol. 176, N 12. -P. 7612-7620.Sj berg A.P., Trouw L.A., McGrath F.D.,Hack C.E., Blom A.M. Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein//J. Immunol. -2006. -Vol. 176, N 12. -P. 7612-7620.Szalai A.J., van Ginkel F.W., Wang Y., McGhee J.R., Volanakis J.E. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component//J. Immunol. -2000. -Vol. 165, N 2. -P. 1030-1035.Szalai A.J., van Ginkel F.W., Wang Y., McGhee J.R., Volanakis J.E. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component//J. Immunol. -2000. -Vol. 165, N 2. -P. 1030-1035.Van Oss C.J. The human complement system in health and disease//Marcel Decker. Inc., 1998.Van Oss C.J. The human complement system in health and disease//Marcel Decker. Inc., 1998.Vinceneux P., Pouchot J. Maladie pйriodique, symptomatologie clinique et biologique//Presse Med.-2005. -Vol. 34, N 13. -P. 938-946.Vinceneux P., Pouchot J. Maladie pйriodique, symptomatologie clinique et biologique//Presse Med.-2005. -Vol. 34, N 13. -P. 938-946.Whaley K., North J. Haemolytic assays for whole complement activity and individual components//Complement. A Practical Approach/Ed. Doods A.W., Sim R.B. -Oxford University Press, 1997. -P. 9-47.Whaley K., North J. Haemolytic assays for whole complement activity and individual components//Complement. A Practical Approach/Ed. Doods A.W., Sim R.B. -Oxford University Press, 1997. -P. 9-47.Yalinkaya F., Cakar N., Acar B., Tutar E., Guriz H., Elhan A.N., Ozturk S., Kansu A.,Yalinkaya F., Cakar N., Acar B., Tutar E., Guriz H., Elhan A.N., Ozturk S., Kansu A.,Ince E., Atalay S., Girgin N., Dogru U., Aysev D., Ekim M. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study//Rheumatol. Int.-2007. -Vol. 27, N 6. -P. 517 -522.Ince E., Atalay S., Girgin N., Dogru U., Aysev D., Ekim M. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study//Rheumatol. Int.-2007. -Vol. 27, N 6. -P. 517 -522.
The authors declare that there are no conflicts of interest present.